Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

Equivalent mismatch negativity deficits across deviant types in early illness schizophrenia-spectrum patients

(2015) Rachel A. Hay et al.   BIOLOGICAL PSYCHOLOGY

Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis

(2014) Rodolfo Solís-Vivanco et al.   SCHIZOPHRENIA RESEARCH

Validating Endophenotypes for Schizophrenia Using Statistical Modeling of Twin Data

(2012) Mei-Hua Hall et al.   CLINICAL EEG AND NEUROSCIENCE

P50 Suppression and Its Neural Generators in Antipsychotic-Naïve First-Episode Schizophrenia Before and After 6 Months of Quetiapine Treatment

(2012) Bob Oranje et al.   SCHIZOPHRENIA BULLETIN

Glutamatergic Modulation of Auditory Information Processing in the Human Brain

(2011) Handan Gunduz-Bruce et al.   BIOLOGICAL PSYCHIATRY

The auditory P200 is both increased and reduced in schizophrenia? A meta-analytic dissociation of the effect for standard and target stimuli in the oddball task

(2011) F. Ferreira-Santos et al.   CLINICAL NEUROPHYSIOLOGY

Decreased Frontal Serotonin2A Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia

(2010) Hans Rasmussen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months’ treatment with quetiapine

(2010) Bodil Aggernaes et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: A pilot study

(2010) E-Jin Park et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine

(2010) Hans Rasmussen et al.   PSYCHOPHARMACOLOGY

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

(2009) M. Wienberg et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Are Auditory-Evoked Frequency and Duration Mismatch Negativity Deficits Endophenotypic for Schizophrenia? High-Density Electrical Mapping in Clinically Unaffected First-Degree Relatives and First-Episode and Chronic Schizophrenia

(2008) Elena Magno et al.   BIOLOGICAL PSYCHIATRY

Reduced auditory evoked potential component N100 in schizophrenia — A critical review

(2008) Timm Rosburg et al.   PSYCHIATRY RESEARCH